| dc.contributor.author | Cabal Naves, Carmen María de la Paz | |
| dc.contributor.author | Long, T. E. | |
| dc.contributor.author | Turos, E. | |
| dc.contributor.author | García Delgado, Ana Belén | |
| dc.contributor.author | Allen, J. L. | |
| dc.contributor.author | Budny, B. G. | |
| dc.contributor.author | Shaw, L. N. | |
| dc.date.accessioned | 2021-01-27T10:18:44Z | |
| dc.date.available | 2021-01-27T10:18:44Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Journal of Antibiotics, 73, p. 868-872 (2020); doi:10.1038/s41429-020-0346-x | |
| dc.identifier.issn | 0021-8820 | |
| dc.identifier.uri | http://hdl.handle.net/10651/57356 | |
| dc.description.sponsorship | Financial support by Asturpharma S.A. and the projects PC-CIS01-22 (FICYT) and PR-01-GE-9 (Grupo de Excelencia FICYT) from the Consejería de Educación y Cultura del Principado de Asturias, and by Banco de Santander-Universidad de Oviedo (CEI “Ad Futurum” 10.01.633B.481.60) is gratefully acknowledged. This work was also supported in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health under award numbers AI151970 (T.E.L) and AI124458 (L.N.S.). | |
| dc.format.extent | p. 868-872 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Antibiotics | |
| dc.rights | © 2020, The Author(s), under exclusive licence to the Japan Antibiotics Research Association | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087715249&doi=10.1038%2fs41429-020-0346-x&partnerID=40&md5=427ce8142deaee13c3b42d1039fb5458 | |
| dc.title | Spiropiperidyl rifabutins: expanded in vitro testing against ESKAPE pathogens and select bacterial biofilms | |
| dc.type | journal article | |
| dc.identifier.doi | 10.1038/s41429-020-0346-x | |
| dc.relation.projectID | Grupo de Excelencia FICYT/PR-01-GE-9 | |
| dc.relation.projectID | FICYT/CIS01-22 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1038/s41429-020-0346-x | |
